Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma

Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma

Background and objectives: Dimensional response is an unmet need in second lines of advanced soft tissue sarcomas (STS). Indeed, the three approved drugs, pazopanib, trabectedin, and eribulin, achieved an overall response rate (ORR) of less than 10%. This fact potentially hinders the options for fas...

Full description

Bibliographic Details
Main Authors:	Javier Martin-Broto, Alicia Olarte-García, Ricardo Fernandéz-Rodríguez, Marta Ribeiro Ferreira, Irene Carrasco-García, Fernando Galvez-Montosa, Inmaculada Rincon-Perez, Javier Peinado-Serrano, Ignacio Azinovic, Laura Guzman-Gomez, Lurdes Salgado, Alberto Sevillano, Justo Ortega, Cristina Alvarez, Antonio Gutierrez, David S. Moura, Nadia Hindi
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-01-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359231225044

Similar Items

Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center
by: Nadia Hindi, et al.
Published: (2020-12-01)

Trabectedin and Radiotherapy in Endometrial Stromal Sarcoma: A Case Report
by: Irene Carrasco García, et al.
Published: (2024-01-01)

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
by: De Sanctis R, et al.
Published: (2015-10-01)

Erratum: Hindi, N., et al. Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center. <em>Cancers</em> 2020, <em>12</em>, 3740
by: Nadia Hindi, et al.
Published: (2021-03-01)

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma [Corrigendum]
by: De Sanctis R, et al.
Published: (2016-01-01)

Leiomyosarcoma of the Inferior Vena Cava: A Case Report of Complete and Sustained Response with Trabectedin
by: André Cruz, et al.
Published: (2016-04-01)

Case Report of Suspected Rhabdomyolysis during Treatment with Trabectedin in a Patient with Metastatic Leiomyosarcoma
by: W. Lamm, et al.
Published: (2010-12-01)

Trabectedin and Radiation Therapy for Cardiac Metastasis From Leiomyosarcoma: A Case Report and Review of the Literature
by: Ilaria Tortorelli, et al.
Published: (2022-04-01)

Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report
by: Viktoria-Anna Nteli, et al.
Published: (2018-02-01)

796 A phase I/II trial combining avelumab and trabectedin for advanced liposarcoma and leiomyosarcoma
by: Michael Wagner, et al.
Published: (2020-11-01)

Long-Time Progression-Free Survival with Trabectedin in Chemorefractory Metastatic Leiomyosarcoma of the Retroperitoneum: A Case Report
by: Andreas Reichinger
Published: (2023-09-01)

Long-Term Response after 94 Cycles of Trabectedin in a Patient with Metastatic Leiomyosarcoma of the Lower Extremity
by: Magda Cordeiro, et al.
Published: (2020-02-01)

Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
by: Eva María Guerra Alía, et al.
Published: (2019-06-01)

Antiangiogenics in Malignant Granular Cell Tumors: Review of the Literature
by: Carlos Torrado, et al.
Published: (2023-10-01)

Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of18FDG-PET-CT in Assessing Treatment Response
by: M.J. Payne, et al.
Published: (2014-02-01)

Trabectedin in Soft Tissue Sarcomas
by: Bradley J. Petek, et al.
Published: (2015-02-01)

Trabectedin – the DNA minor groove binder
by: G. A. Belitsky, et al.
Published: (2015-06-01)

Trabectedin for the treatment of relapsed ovarian cancer
by: D Papaioannou, et al.
Published: (2011-05-01)

The Role of Trabectedin in Soft Tissue Sarcoma
by: Tomoki Nakamura, et al.
Published: (2022-02-01)

Determination of Extravasation Effects of Nal-Iri and Trabectedin and Evaluation of Treatment Options for Trabectedin Extravasation in a Preclinical Animal Model
by: Omar Keritam, et al.
Published: (2022-06-01)

Efficacy of trabectedin in metastatic solitary fibrous tumor
by: Xavier Pivot, et al.
Published: (2011-07-01)

Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma
by: Csaba Gajdos, et al.
Published: (2011-01-01)

The value of trabectedin in the treatment of soft tissue sarcoma
by: Nakamura T, et al.
Published: (2016-01-01)

<i>CUL4A</i>, <i>ERCC5</i>, and <i>ERCC1</i> as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
by: David S. Moura, et al.
Published: (2020-04-01)

In-Silico Identification of Novel Pharmacological Synergisms: The Trabectedin Case
by: Laura Mannarino, et al.
Published: (2024-02-01)

Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients
by: Giuseppe Corona, et al.
Published: (2023-08-01)

Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
by: EL Simpson, et al.
Published: (2010-05-01)

New developments in treatment of ovarian carcinoma: focus on trabectedin
by: Philippe A Cassier, et al.
Published: (2010-10-01)

Trabectedin and its potential in the treatment of soft tissue sarcoma
by: Philippe A Cassier, et al.
Published: (2008-03-01)

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
by: Javier Martínez-Trufero, et al.
Published: (2021-02-01)

Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models
by: Lucia Martinez-Cruzado, et al.
Published: (2017-06-01)

Leiomyosarcoma of the Penis, an Exceptional Entity
by: Edwin Javier Romero Gonzalez, et al.
Published: (2015-05-01)

Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells
by: Mauro Loi, et al.
Published: (2022-11-01)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
by: Carlos M. Galmarini, et al.
Published: (2014-01-01)

Effects of trabectedin in the zebrafish Danio rerio: from cells to larvae
by: Évila Pinheiro Damasceno, et al.
Published: (2022-07-01)

Toxicity of trabectedin-based combinations in the treatment of different malignant tumors
by: M V Cherkasova, et al.
Published: (2013-06-01)

The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer
by: M V Cherkasova, et al.
Published: (2013-12-01)

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
by: Audrey Laroche, et al.
Published: (2017-04-01)

Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
by: Maria Cucè, et al.
Published: (2019-03-01)

Specific Effects of Trabectedin and Lurbinectedin on Human Macrophage Function and Fate—Novel Insights
by: Adrián Povo-Retana, et al.
Published: (2020-10-01)